TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Agnosia Treatment Market, by Diagnosis
6.1 Introduction
6.2 Computed Tomography (CT)
6.2.1 Market Estimates & Forecast, 2020 – 2027
6.3 Magnetic Resonance Imaging (MRI)
6.3.1 Market Estimates & Forecast, 2020 – 2027
6.4 Others
6.4.1 Market Estimates & Forecast, 2020 – 2027
Chapter 7. Global Agnosia Treatment Market, by Cause
7.1 Introduction
7.2 Alzheimer's disease
7.2.1 Market Estimates & Forecast, 2020 – 2027
7.3 Pick's disease
7.3.1 Market Estimates & Forecast, 2020 – 2027
7.4 MELAS
7.4.1 Market Estimates & Forecast, 2020 – 2027
7.5 Balint's syndrome
7.5.1 Market Estimates & Forecast, 2020 – 2027
Chapter 8. Global Agnosia Treatment Market, by Type
8.1 Introduction
8.2 Auditory agnosia
8.2.1 Market Estimates & Forecast, 2020 – 2027
8.3 Gustatory agnosia
8.3.2 Market Estimates & Forecast, 2020 – 2027
8.4 Olfactory agnosia
8.4.2 Market Estimates & Forecast, 2020 – 2027
8.5 Tactile agnosia
8.5.2 Market Estimates & Forecast, 2020 – 2027
8.6 Visual agnosia
8.6.2 Market Estimates & Forecast, 2020 – 2027
8.7 Others
8.7.1 Market Estimates & Forecast, 2020 – 2027
8.7.2 Prosopagnosia
8.7.2.1 Market Estimates & Forecast, 2020 – 2027
8.7.3 Anosognosia
8.7.3.1 Market Estimates & Forecast, 2020 – 2027
Chapter 9. Global Agnosia Treatment Market, by Treatment
9.1 Introduction
9.2 Surgery
9.2.1 Market Estimates & Forecast, 2020 – 2027
9.3 Antibiotics for cerebral absess
9.3.1 Market Estimates & Forecast, 2020 – 2027
9.3.2 Ceftriaxone
9.3.2.1 Market Estimates & Forecast, 2020 – 2027
9.3.3 Cefotaxime+metronidazole
9.3.3.1 Market Estimates & Forecast, 2020 – 2027
9.4 Radiation of brain tumor
9.4.1 Market Estimates & Forecast, 2020 – 2027
Chapter .10 Global Agnosia Treatment Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Fujifilm Holdings
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 GE Healthcare
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Siemens Healthcare
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Philips Healthcare
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 B. Braun Melsungen
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Pfizer Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 F. Hoffmann-La Roche AG
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Lupin Ltd.
12.8.1 Company Overview
12.8.2 Product/Business Segment Overview
12.8.3 Financial Overview
12.8.4 Key Development
12.8.5 SWOT Analysis
12.9 Fresenius Kabi Ipsum SRL
12.9.1 Company Overview
12.9.2 Product Overview
12.9.3 Financial overview
12.9.4 Key Developments
12.10 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pharmaceutical industry
Chapter 14 Appendix
LIST OF TABLES
Table 1 Agnosia Treatment Industry Synopsis, 2020 – 2027
Table 2 Agnosia Treatment Market Estimates and Forecast, 2020 – 2027, (USD Million)
Table 3 Agnosia Treatment Market by Region, 2020 – 2027, (USD Million)
Table 4 Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 5 Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 6 Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 7 North America Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 8 North America Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 9 North America Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 10 US Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 11 US Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 12 US Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 13 Canada Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 14 Canada Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 15 Canada Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 16 South America Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 17 South America Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 18 South America Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 19 Europe Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 20 Europe Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 21 Europe Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 22 Western Europe Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 23 Western Europe Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 24 Western Europe Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 25 Eastern Europe Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 26 Eastern Europe Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 27 Eastern Europe Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 28 Asia Pacific Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 29 Asia Pacific Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 30 Asia Pacific Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 31 Middle East & Africa Agnosia Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 32 Middle East & Africa Agnosia Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 33 Middle East & Africa Agnosia Treatment Market by End Users, 2020 – 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Agnosia Treatment Market
Figure 3 Segmentation Market Dynamics for Agnosia Treatment Market
Figure 4 Global Agnosia Treatment Market Share, by Diagnosis 2020
Figure 5 Global Agnosia Treatment Market Share, by Treatment 2020
Figure 6 Global Agnosia Treatment Market Share, by End Users, 2020
Figure 7 Global Agnosia Treatment Market Share, by Region, 2020
Figure 8 North America Agnosia Treatment Market Share, by Country, 2020
Figure 9 Europe Agnosia Treatment Market Share, by Country, 2020
Figure 10 Asia Pacific Agnosia Treatment Market Share, by Country, 2020
Figure 11 Middle East & Africa Agnosia Treatment Market Share, by Country, 2020
Figure 12 Global Agnosia Treatment Market: Company Share Analysis, 2020 (%)
Figure 13 Fujifilm Holdings: Key Financials
Figure 14 Fujifilm Holdings: Segmental Revenue
Figure 15 Fujifilm Holdings: Geographical Revenue
Figure 16 GE Healthcare: Key Financials
Figure 17 GE Healthcare: Segmental Revenue
Figure 18 GE Healthcare: Geographical Revenue
Figure 19 Siemens Healthcare: Key Financials
Figure 20 Siemens Healthcare: Segmental Revenue
Figure 21 Siemens Healthcare: Geographical Revenue
Figure 22 Philips Healthcare: Key Financials
Figure 23 Philips Healthcare: Segmental Revenue
Figure 24 Philips Healthcare: Geographical Revenue
Figure 25 B. Braun Melsungen: Key Financials
Figure 26 B. Braun Melsungen: Segmental Revenue
Figure 27 B. Braun Melsungen: Geographical Revenue
Figure 28 Pfizer Inc.: Key Financials
Figure 29 Pfizer Inc.: Segmental Revenue
Figure 30 Pfizer Inc.: Geographical Revenue
Figure 31 F. Hoffmann-La Roche AG: Key Financials
Figure 32 F. Hoffmann-La Roche AG: Segmental Revenue
Figure 33 F. Hoffmann-La Roche AG: Geographical Revenue
Figure 34 Lupin ltd.: Key Financials
Figure 35 Lupin ltd.: Segmental Revenue
Figure 36 Lupin ltd.: Geographical Revenue
Figure 37 Fresenius Kabi Ipsum SRL: Key Financials
Figure 38 Fresenius Kabi Ipsum SRL: Segmental Revenue
Figure 39 Fresenius Kabi Ipsum SRL: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
